202 related articles for article (PubMed ID: 11517177)
1. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes.
Shoba LN; Newman M; Liu W; Lowe WL
Endocrinology; 2001 Sep; 142(9):3980-6. PubMed ID: 11517177
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways.
Hagemeister AL; Sheridan MA
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R490-7. PubMed ID: 18495839
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
4. Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death.
Liu W; Chin-Chance C; Lee EJ; Lowe WL
Endocrinology; 2002 Oct; 143(10):3802-12. PubMed ID: 12239091
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-stimulated insulin-like growth factor-1 expression in rainbow trout (Oncorhynchus mykiss) hepatocytes is mediated by ERK, PI3K-AKT, and JAK-STAT.
Reindl KM; Kittilson JD; Bergan HE; Sheridan MA
Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R236-43. PubMed ID: 21490369
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells.
Monno S; Newman MV; Cook M; Lowe WL
Endocrinology; 2000 Feb; 141(2):544-50. PubMed ID: 10650934
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
8. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
10. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
Imai Y; Clemmons DR
Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
12. Involvement of both phosphatidylinositol 3-kinase and p44/p42 mitogen-activated protein kinase pathways in the short-term regulation of pyruvate kinase L by insulin.
Carrillo JJ; Ibares B; Esteban-Gamboa A; Felíu JE
Endocrinology; 2001 Mar; 142(3):1057-64. PubMed ID: 11181519
[TBL] [Abstract][Full Text] [Related]
13. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.
Nguyen KT; Wang WJ; Chan JL; Wang LH
Oncogene; 2000 Nov; 19(47):5385-97. PubMed ID: 11103940
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
16. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
Zhang D; Bar-Eli M; Meloche S; Brodt P
J Biol Chem; 2004 May; 279(19):19683-90. PubMed ID: 14993222
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells.
Benbassat C; Shoba LN; Newman M; Adamo ML; Frank SJ; Lowe WL
Endocrinology; 1999 Jul; 140(7):3073-81. PubMed ID: 10385399
[TBL] [Abstract][Full Text] [Related]
18. Follicle-stimulating hormone and insulin-like growth factor I synergistically induce up-regulation of cartilage link protein (Crtl1) via activation of phosphatidylinositol-dependent kinase/Akt in rat granulosa cells.
Sun GW; Kobayashi H; Suzuki M; Kanayama N; Terao T
Endocrinology; 2003 Mar; 144(3):793-801. PubMed ID: 12586755
[TBL] [Abstract][Full Text] [Related]
19. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 induces growth, survival and morphological change of primary hepatocytes on a galactose-bared polymer through both MAPK and beta-catenin pathways.
Kundu AK; Nagaoka M; Chowdhury EH; Hirose S; Sasagawa T; Akaike T
Cell Struct Funct; 2003 Aug; 28(4):255-63. PubMed ID: 14586135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
